Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175356381> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W3175356381 endingPage "107237" @default.
- W3175356381 startingPage "107237" @default.
- W3175356381 abstract "Dapagliflozin is a highly selective sodium-glucose cotransporter 2 inhibitor associated with stabilization of estimated glomerular filtration rate (eGFR); reductions in glycated hemoglobin (HbA1c), systolic blood pressure, body weight, and albuminuria; and a small and consistent increase in hematocrit [1] , [2] , [3] , [4] . This data set is based on the associated article [5] analyzing data from 5325 patients with type 2 diabetes from 14 placebo-controlled, phase 3 (one phase 2/3), double-blind dapagliflozin treatment studies of 24–104 weeks’ duration. Data on dapagliflozin's effects (vs. placebo) on hemoglobin (Hb), hematocrit, serum albumin, serum total protein concentrations, urine albumin/creatinine ratio, eGFR, heart rate, blood pressure, body weight, and safety in patients with type 2 diabetes with and without anemia were pooled and analyzed. Patients were divided into two groups according to baseline Hb levels: anemia (Hb <13 g/dL in men and <12 g/dL in women) and no anemia. Some biomarkers associated with erythropoiesis and the presence of anemia, such as iron, transferrin, ferritin, reticulocytes, and hepcidin, were not included in the original studies and therefore data for these biomarkers were not available. Descriptive statistics were used for baseline characteristics and safety data and a longitudinal repeated-measures mixed model for efficacy data. Changes in Hb concentrations were evaluated, and the proportion of patients with baseline anemia who were no longer anemic at week 24 was determined, as was the occurrence of polycythemia (Hb >16.5 g/dL in men and >16.0 g/dL in women). Because anemia commonly occurs in patients with diabetes and chronic kidney disease [6] , the data can be of value to further analyze trends in relevant physiological and pathophysiological parameters." @default.
- W3175356381 created "2021-07-05" @default.
- W3175356381 creator A5020663562 @default.
- W3175356381 creator A5031624913 @default.
- W3175356381 creator A5037748733 @default.
- W3175356381 creator A5041913215 @default.
- W3175356381 creator A5049170733 @default.
- W3175356381 creator A5060560730 @default.
- W3175356381 creator A5069865054 @default.
- W3175356381 creator A5084032669 @default.
- W3175356381 date "2021-08-01" @default.
- W3175356381 modified "2023-10-18" @default.
- W3175356381 title "Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline" @default.
- W3175356381 cites W1946504369 @default.
- W3175356381 cites W2153839551 @default.
- W3175356381 cites W2418756187 @default.
- W3175356381 cites W2436309489 @default.
- W3175356381 cites W2606595268 @default.
- W3175356381 cites W3083634046 @default.
- W3175356381 doi "https://doi.org/10.1016/j.dib.2021.107237" @default.
- W3175356381 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8255174" @default.
- W3175356381 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34258337" @default.
- W3175356381 hasPublicationYear "2021" @default.
- W3175356381 type Work @default.
- W3175356381 sameAs 3175356381 @default.
- W3175356381 citedByCount "0" @default.
- W3175356381 crossrefType "journal-article" @default.
- W3175356381 hasAuthorship W3175356381A5020663562 @default.
- W3175356381 hasAuthorship W3175356381A5031624913 @default.
- W3175356381 hasAuthorship W3175356381A5037748733 @default.
- W3175356381 hasAuthorship W3175356381A5041913215 @default.
- W3175356381 hasAuthorship W3175356381A5049170733 @default.
- W3175356381 hasAuthorship W3175356381A5060560730 @default.
- W3175356381 hasAuthorship W3175356381A5069865054 @default.
- W3175356381 hasAuthorship W3175356381A5084032669 @default.
- W3175356381 hasBestOaLocation W31753563811 @default.
- W3175356381 hasConcept C126322002 @default.
- W3175356381 hasConcept C134018914 @default.
- W3175356381 hasConcept C142724271 @default.
- W3175356381 hasConcept C159641895 @default.
- W3175356381 hasConcept C204787440 @default.
- W3175356381 hasConcept C27081682 @default.
- W3175356381 hasConcept C2776174234 @default.
- W3175356381 hasConcept C2777180221 @default.
- W3175356381 hasConcept C2777422806 @default.
- W3175356381 hasConcept C2777538456 @default.
- W3175356381 hasConcept C2778248108 @default.
- W3175356381 hasConcept C2778917026 @default.
- W3175356381 hasConcept C2780306776 @default.
- W3175356381 hasConcept C2780959883 @default.
- W3175356381 hasConcept C555293320 @default.
- W3175356381 hasConcept C67761136 @default.
- W3175356381 hasConcept C71924100 @default.
- W3175356381 hasConcept C84393581 @default.
- W3175356381 hasConcept C90924648 @default.
- W3175356381 hasConceptScore W3175356381C126322002 @default.
- W3175356381 hasConceptScore W3175356381C134018914 @default.
- W3175356381 hasConceptScore W3175356381C142724271 @default.
- W3175356381 hasConceptScore W3175356381C159641895 @default.
- W3175356381 hasConceptScore W3175356381C204787440 @default.
- W3175356381 hasConceptScore W3175356381C27081682 @default.
- W3175356381 hasConceptScore W3175356381C2776174234 @default.
- W3175356381 hasConceptScore W3175356381C2777180221 @default.
- W3175356381 hasConceptScore W3175356381C2777422806 @default.
- W3175356381 hasConceptScore W3175356381C2777538456 @default.
- W3175356381 hasConceptScore W3175356381C2778248108 @default.
- W3175356381 hasConceptScore W3175356381C2778917026 @default.
- W3175356381 hasConceptScore W3175356381C2780306776 @default.
- W3175356381 hasConceptScore W3175356381C2780959883 @default.
- W3175356381 hasConceptScore W3175356381C555293320 @default.
- W3175356381 hasConceptScore W3175356381C67761136 @default.
- W3175356381 hasConceptScore W3175356381C71924100 @default.
- W3175356381 hasConceptScore W3175356381C84393581 @default.
- W3175356381 hasConceptScore W3175356381C90924648 @default.
- W3175356381 hasFunder F4320307770 @default.
- W3175356381 hasLocation W31753563811 @default.
- W3175356381 hasLocation W31753563812 @default.
- W3175356381 hasLocation W31753563813 @default.
- W3175356381 hasLocation W31753563814 @default.
- W3175356381 hasLocation W31753563815 @default.
- W3175356381 hasLocation W31753563816 @default.
- W3175356381 hasOpenAccess W3175356381 @default.
- W3175356381 hasPrimaryLocation W31753563811 @default.
- W3175356381 hasRelatedWork W2148414105 @default.
- W3175356381 hasRelatedWork W2375101873 @default.
- W3175356381 hasRelatedWork W2467488710 @default.
- W3175356381 hasRelatedWork W2530393017 @default.
- W3175356381 hasRelatedWork W2748375747 @default.
- W3175356381 hasRelatedWork W3010935120 @default.
- W3175356381 hasRelatedWork W3086148163 @default.
- W3175356381 hasRelatedWork W3119567526 @default.
- W3175356381 hasRelatedWork W3175356381 @default.
- W3175356381 hasRelatedWork W4233745978 @default.
- W3175356381 hasVolume "37" @default.
- W3175356381 isParatext "false" @default.
- W3175356381 isRetracted "false" @default.
- W3175356381 magId "3175356381" @default.
- W3175356381 workType "article" @default.